Ben Cohen, MD
Retina Specialist · New York, NYNPI 1083608186
Payments from drug & device makers
Across 239 payments — averaging $413.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Global Development$93K
- Carl Zeiss Meditec, Inc.$1K
- Johnson & Johnson$654
- Alcon$591
- AbbVie$406
- Johnson & Johnson Surgical Vision, Inc.$351
- plus $2K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Global Development | 128 | $93,369 |
| Carl Zeiss Meditec, Inc. | 1 | $1,300 |
| Johnson & Johnson | 8 | $654 |
| Alcon | 29 | $591 |
| AbbVie(2 entities) | 14 | $406 |
| Johnson & Johnson Surgical Vision, Inc. | 12 | $351 |
| Alimera Sciences, Inc. | 2 | $275 |
| Regeneron Healthcare Solutions, Inc. | 10 | $251 |
| Alphatec Spine, Inc | 1 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $234 |
| Rxsight Inc | 2 | $196 |
| Novartis | 4 | $175 |
| Genentech, Inc. | 1 | $150 |
| Bausch & Lomb Americas Inc. | 7 | $144 |
| Apellis Pharmaceuticals, Inc. | 2 | $115 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $89 |
| Iridex Corporation | 1 | $78 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 2 | $47 |
| UCB, Inc. | 3 | $42 |
| Astellas Pharma US Inc | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Glaukos Corporation | 1 | $21 |
| Dutch Ophthalmic, USA | 1 | $18 |
How this compares
$98,829 in reported general payments places this provider in the 85th percentile of 99 retina specialist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in New York
- Szilard KissNew York$222K
- Donald D'amicoNew York$109K
- Gareth LemaNew York$11K
- Megan Ridley LaneNew York$11K
- Carl WilkinsNew York$9K
- Gennady LandaNew York$7K
- Joseph TsengNew York$6K
- Alan SheymanNew York$4K
- Steven AgemyNew York$3K
- Louis AngiolettiNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.